另类投资机构EQT VIII同意将Karo Healthcare出售给KKR-动脉网

EQT to sell Karo Healthcare, a Leading Pan-European Consumer health Platform, to KKR

CISION 等信源发布 2025-04-09 17:52



可切换为仅中文







Under EQT's ownership, Karo has transformed from a Nordic specialty pharma business into a pan-European consumer healthcare platform, driven by strong organic growth, eight strategic acquisitions, and investment in digitalisation and in-house commercial capabilities

在EQT的所有权下，Karo已经从一家北欧专业制药企业转变为一家泛欧洲的消费者医疗保健平台，这一转变得益于强劲的有机增长、八项战略性收购以及在数字化和内部商业化能力上的投资。

KKR will support Karo's continued growth by leveraging its deep sector expertise, global network, and a long-term investment approach to drive innovation, internationalization, and further brand growth and acquisitions

KKR 将利用其深厚的行业专业知识、全球网络和长期投资策略，推动创新、国际化以及进一步的品牌增长和收购，从而支持 Karo 的持续发展。

Karo now operates a diversified portfolio of trusted consumer health brands with leadership positions in European markets and a scalable, digitally enabled platform

Karo目前经营着一个多元化的、值得信赖的消费者健康品牌组合，在欧洲市场占据领导地位，并拥有一个可扩展的、数字化赋能的平台。

STOCKHOLM

斯德哥尔摩

，

April 9, 2025

2025年4月9日

/PRNewswire/ -- EQT and KKR today announced that EQT VIII fund ('EQT') has agreed to sell Karo Healthcare ('Karo' or the 'Company') to KKR. The acquisition marks the next chapter for Karo, as it continues to accelerate its growth strategy under KKR's ownership, building on its transformation into one of .

/PRNewswire/ -- EQT和KKR今天宣布，EQT VIII基金（“EQT”）已同意将Karo Healthcare（“Karo”或“公司”）出售给KKR。此次收购标志着Karo的新篇章，公司将在KKR的所有权下继续加速其增长战略，基于其转型为其中之一。

Europe's

欧洲的

leading consumer health platforms since EQT's initial investment.

自EQT初始投资以来的领先消费者健康平台。

Karo is a leading pan-European consumer healthcare company headquartered in

Karo是一家总部位于欧洲的领先的泛欧消费者医疗保健公司

Stockholm, Sweden

瑞典，斯德哥尔摩

. The Company operates an attractive product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. During the past five years, Karo has scaled substantially, quadrupling in sales, building leading digital capabilities and establishing market presence to reach consumers in more than 90 countries with top brand positions across European markets..

公司经营着一个有吸引力的产品组合，涵盖核心类别，如皮肤健康、足部健康、亲密健康，以及消化健康和维生素、矿物质及补充剂。在过去的五年里，Karo规模大幅扩张，销售额翻了两番，建立了领先的数字能力，并在90多个国家建立了市场存在感，在欧洲市场拥有顶级品牌地位。

Under EQT's ownership since 2019, Karo has undergone a significant strategic repositioning, shifting from a specialty pharmaceutical company focused on the Nordics into becoming a pan-European pure-play consumer healthcare platform. During this time, with M&A having been a cornerstone of Karo's growth strategy, Karo completed eight acquisitions from industry players which have enriched Karo's portfolio, strengthened its presence in key markets, and accelerated its entry into new geographies..

自2019年EQT收购以来，Karo经历了重大的战略转型，从一家专注于北欧地区的专业制药公司转变为一个泛欧洲的纯消费保健品平台。在此期间，并购一直是Karo增长战略的基石，Karo完成了八次行业参与者的收购，这些收购丰富了Karo的产品组合，加强了其在关键市场的地位，并加速了其进入新地域的步伐。

Commenting on the transaction,

评论这笔交易，

Christoffer Lorenzen

克里斯托弗·洛伦岑

, CEO of Karo Healthcare

，Karo Healthcare首席执行官

, said: 'We're incredibly proud of what we've achieved in recent years and grateful to EQT for their partnership, which has been instrumental in helping us grow and evolve into the business we are today. With KKR as our new owner, we are entering an exciting next phase in our journey. Their global reach, deep sector understanding, and long-term approach make them the ideal strategic partner as we continue to invest in our brands, expand into new markets and meet the evolving health needs of consumers.'.

表示：“我们为近年来取得的成就感到无比自豪，也非常感谢EQT的合作伙伴关系，这对我们的成长和发展起到了至关重要的作用，使我们成为今天的公司。随着KKR成为我们的新所有者，我们将进入发展历程中令人兴奋的下一阶段。他们的全球影响力、深厚的行业理解以及长期战略方法，使他们成为我们在继续投资品牌、拓展新市场以及满足消费者不断变化的健康需求过程中的理想战略伙伴。”

'Karo is a textbook example of EQT's approach – scaling a local company into a fast-growing sector champion with international reach,' said

“Karo 是 EQT 方法的教科书式案例——将一家本地公司发展为快速增长、具有国际影响力的行业领军者，”

Erika Henriksson

艾丽卡·亨里克森

, Partner in the EQT Private Equity advisory team

，EQT私募股权咨询团队的合伙人

. 'Thanks to its consumer centricity, strong M&A track record, and proven brand growth playbooks, Karo is now primed to further expand on its leadership position. We're proud of what Christoffer and the team have achieved and excited to hand over to a new owner for the next phase.'

“得益于其以消费者为中心、强大的并购记录以及经过验证的品牌增长策略，Karo现在已经准备好进一步扩大其领导地位。我们为克里斯托弗和团队取得的成就感到自豪，并期待将接力棒交给新主人，开启下一个阶段。”

Inaki Cobo

伊纳基·科博

, Partner at KKR

，KKR合伙人

, said: 'Karo is a unique platform with high-quality brands, strong digital and commercial capabilities, and a proven strong leadership team. We are thrilled to invest in this European champion's next phase of growth, drawing on our deep experience in the consumer health space to support continued expansion, innovation, and organic and inorganic growth.' .

表示：“Karo 是一个独特的平台，拥有高质量的品牌、强大的数字和商业能力，以及经过验证的强大领导团队。我们很高兴能够投资这家欧洲冠军企业，利用我们在消费者健康领域的深厚经验，支持其持续扩张、创新以及有机和非有机增长的下一阶段发展。”

Hans Arstad

汉斯·阿尔斯塔德

, Managing Director at KKR

KKR董事总经理

, added: 'Karo operates in a resilient, growing sector supported by long-term demographic trends and increasing consumer focus on wellness and self-care. We engaged the full capabilities of our firm to deliver this transaction during a period of market disruption and we look forward to supporting Karo's growth as a value-enhancing strategic partner.'.

，补充道：“Karo处于一个由长期人口趋势及消费者对健康和自我护理日益关注所支持的弹性增长领域。我们在市场动荡时期充分利用公司的全部能力完成了这项交易，我们期待作为增值战略伙伴支持Karo的成长。”

The transaction is subject to customary regulatory conditions and approvals and is expected to close in the coming months. EQT was advised by Morgan Stanley, Jeffries, White & Case and PwC. Citigroup acted as financial advisor to KKR.

该交易受惯例监管条件和审批的约束，预计将在未来几个月内完成。EQT 得到了摩根士丹利、杰富瑞、伟凯律师事务所和普华永道的建议。花旗集团担任 KKR 的财务顾问。

Media Contacts

媒体联系人

EQT Press Office,

EQT新闻办公室，

press@eqtpartners.com

KKR, Alastair Elwen,

KKR，阿拉斯泰尔·埃尔文，

alastair.elwen@fgsglobal.com

This information was brought to you by Cision

此信息由Cision提供

http://news.cision.com